|4Feb 25, 5:13 PM ET

BIRD ROGER 4

4 · ABBOTT LABORATORIES · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-21
BIRD ROGER
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2020-02-21+14,37571,322 total
  • Award

    Option (right to buy)

    2020-02-21+87,62887,628 total
    Exercise: $87.72From: 2021-02-21Exp: 2030-02-20Common shares (87,628 underlying)
Footnotes (2)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,209 on February 21, 2021, 29,209 on February 21, 2022, and 29,210 on February 21, 2023.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -